News
Ionis Beats Q3 Earnings & Sales Estimates, Raises 2025 Outlook
Ionis Pharmaceuticals IONS reported third-quarter 2025 adjusted loss per share of 61 cents, much narrower than the Zacks Consensus Estimate of a loss of $1.15. In the year-ago period, the company
Dayforce Q3 Earnings Miss Estimates, Revenues Rise Y/Y, Shares Up
Dayforce DAY reported third-quarter 2025 earnings of 37 cents per share, which missed the Zacks Consensus Estimate by 33.93% and decreased 21.3% year over year.Revenues of $481.6 million were in
Cigna Q3 Earnings Beat Estimates on Evernorth Health Unit Strength
The Cigna Group CI reported third-quarter 2025 adjusted earnings per share (EPS) of $7.83, which beat the Zacks Consensus Estimate by 1.7%. The bottom line advanced 4% year over year.
Adjusted
SCI Q3 Earnings & Revenues Top Estimates, 2025 Cash Flow View Raised
Service Corporation International SCI posted impressive third-quarter 2025 results, with both top and bottom lines increasing year over year and beating the Zacks Consensus Estimate. The company
FOXA Q1 Earnings Surpass Estimates, Revenues Increase Y/Y
Fox Corporation FOXA reported first-quarter fiscal 2026 adjusted earnings per share of $1.51, which beat the Zacks Consensus Estimate by 42.45%. The figure increased 4.1% year over year.Revenues
L3Harris Beats Q3 Earnings Estimates, Raises '25 Revenue View
L3Harris Technologies, Inc. LHX reported third-quarter 2025 adjusted earnings (from continuing operations) of $2.70 per share, which beat the Zacks Consensus Estimate of $2.56 by 5.5%. The bottom
Worried About an AI Bubble? Look to Surging International Stocks
U.S. stocks continue to climb the wall of worry and post new records. The S&P 500 Index (SPY) is now up more than 17% year to date and is on track to achieve double-digit returns for the third
Equinix Q3 AFFO Beats Estimates, Recurring Revenues Rise Y/Y
Equinix Inc.’s EQIX third-quarter 2025 adjusted funds from operations (AFFO) per share of $9.83 beat the Zacks Consensus Estimate of $9.26. Moreover, the figure improved 8.6% from the prior-year
S&P Global Q3 Earnings & Revenues Outpace Estimates, Increase Y/Y
S&P Global Inc. SPGI has reported impressive third-quarter 2025 results, wherein earnings and revenues surpassed the Zacks Consensus Estimate.
SPGI’s adjusted earnings per share (EPS) of $4.73
ITT's Q3 Earnings & Revenues Top Estimates, Increase Y/Y
ITT Inc.’s ITT third-quarter 2025 adjusted earnings of $1.78 per share surpassed the Zacks Consensus Estimate of $1.67. The bottom line jumped 21.1% year over year, aided by an increase in sales
LKQ's Q3 Earnings Outpace Estimates, Revenues Fall Short
LKQ Corporation LKQ delivered third-quarter 2025 adjusted earnings of 84 cents per share, which exceeded the Zacks Consensus Estimate of 74 cents but declined from 88 cents reported in the year-ago
Huntington Ingalls Q3 Earnings Beat Estimates, Revenues Rise Y/Y
Huntington Ingalls Industries, Inc.’s HII third-quarter 2025 earnings of $3.68 per share declined 43.8% from $2.56 in the prior-year quarter. The bottom line also beat the Zacks Consensus Estimate
EG Q3 Earnings & Revenues Miss Estimates on Poor Underwriting Show
Everest Group, Ltd.’s EG third-quarter 2025 operating income of $7.54 per share missed the Zacks Consensus Estimate by 43.7%. Also, the bottom line decreased 48.4% year over year. The company
Clorox Q1 Earnings Preview: Can It Beat Estimates Amid Headwinds?
The Clorox Company CLX is slated to report first-quarter fiscal 2026 earnings on Nov. 3, after market close. The company is expected to register year-over-year top and bottom-line declines when it
Alphabet's Q3 Earnings Beat Estimates, Revenues Increase Y/Y
Alphabet’s GOOGL third-quarter 2025 earnings of $2.87 per share beat the Zacks Consensus Estimate by 26.99% and jumped 35.4% year over year. Revenues of $102.35 billion increased 16% year over year
Ameriprise Q3 Earnings Beat on Higher Revenues & AUM Growth
Ameriprise Financial’s AMP third-quarter 2025 adjusted operating earnings of $9.92 per share handily surpassed the Zacks Consensus Estimate of $9.60. The bottom line reflected a rise of 12.3% from
Lilly Beats on Q3 Earnings, Ups View, Mounjaro, Zepbound Drive Sales
Eli Lilly and Company LLY reported third-quarter 2025 adjusted earnings per share (“EPS”) of $7.02, which beat the Zacks Consensus Estimate of $6.02 per share. In the year-ago quarter, Lilly
FMC Q3 Earnings Increase, Sales Decline on Lower Prices
FMC Corporation FMC reported a loss of $4.52 per share for third-quarter 2025. This compares unfavorably to earnings of 52 cents in the year-ago quarter.
Barring one-time items, adjusted earnings
Moelis & Company Q3 Earnings Beat on Higher Revenues, Stock Dips
Moelis & Company’s MC third-quarter 2025 adjusted earnings of 68 cents per share surpassed the Zacks Consensus Estimate of 57 cents. The bottom line improved significantly from 22 cents in the
Prudential Financial Q3 Earnings Beat Estimates on Lower Expenses
Prudential Financial, Inc. PRU reported third-quarter 2025 adjusted operating income of $4.26 per share, which beat the Zacks Consensus Estimate by 16.3%. The bottom line increased 28% year over
Builders FirstSource Beats on Q3 Earnings Despite Housing Weakness
Builders FirstSource, Inc. BLDR delivered better-than-expected third-quarter 2025 results, beating the Zacks Consensus Estimates on both earnings and revenues even as a weak housing backdrop
Is Apple the Best Magnificent 7 Stock?
Apple (AAPL) heads into its earnings report Thursday after the close with renewed momentum after a sluggish start to the year. Year-to-date, Apple shares are up roughly 8%, ahead of only Amazon, but
IP Earnings & Sales Miss Estimates in Q3 on Lower Volumes
International Paper Company IP has reported third-quarter 2025 adjusted loss of 43 cents per share, which missed the Zacks Consensus Estimate for earnings of 53 cents. This includes $675 million of
MGM Resorts Q3 Earnings Miss Estimates, Revenues Rise Y/Y, Stock Down
AvalonBay Q3 FFO & Revenues Miss Estimates, '25 Outlook Lowered
AvalonBay Communities AVB reported third-quarter 2025 core funds from operations (FFO) per share of $2.75, missing the Zacks Consensus Estimate of $2.81. However, the figure increased marginally


